Abstract:Background Myocardial infarction (MI) is associated with sympathetic overactivity, during which the co-release of neuropeptide-Y (NPY) is prominent. NPY is associated with arrhythmia risk and mortality following ST-elevation MI, although the exact mechanisms for this in human cardiomyocytes remains unclear. Purpose We therefore tested the hypothesis that NPY signalling would alter the electrophysiology of human induced-pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) in a way that would promote arrhythmia, and that in patients being treated for MI, high NPY concentrations previously associated with ventricular arrhythmia (>27.3 pg.mL-1) would be associated with comparable ECG changes. Methods Immunohistochemistry and western blot were performed on hiPSC-CMs and ventricular biopsies from human patients undergoing valve surgery. The FRET-based sensor Epac-SH187 was expressed in hiPSC-CMs to monitor the cyclic adenosine 3',5'-monophosphate (cAMP) response to NPY. A micro-electrode array was used to investigate the effects of NPY on a confluent layer of iPSC-CMs, measuring changes in activation, recovery, conduction velocity and spontaneous automaticity. Additionally, patients presenting with ST-elevation MI had peripheral venous [NPY] measured and compared to 12-lead ECGs recorded following stenting. Results hiPSC-CMs expressed Y1 and Y5 receptor mRNA and protein, which are also expressed in ventricular biopsies from human patients. NPY (1-100 nM) significantly reduced intracellular cAMP levels (n=65), most effectively prevented by Y5 receptor inhibition (1μM CGP71683A, n=40). In a confluent layer of hiPSC-CM, NPY (100 nM) slowed late-repolarisation represented by T-wave peak-end duration (p=0.04), which could be prevented by Y1-receptor inhibition (1 μM BIBO 3304, n=6), and caused prolongation of rate corrected activation-recovery interval (ARIc) (p=0.009, n=6) which could be abolished by Y5-receptor inhibition (n=7). NPY significantly increased automaticity to more than one site of initiation in 4/6 (66.7%) compared to 2/14 (14.3%) control plates (p=0.037), despite no change in conduction velocity. Moreover, in 65 patients being treated for ST elevation MI, those with high peripheral venous NPY concentrations were well matched in terms of cardiovascular risk factors, medications on admission, and pain to balloon times, but had significantly longer corrected QT interval (QTc) on the 12 lead ECG (p=0.04) despite no differences in PR interval, heart rate or electrolyte concentrations. Conclusions NPY slowed late repolarisation and caused ARIc prolongation, which was associated with increased automaticity in human iPSC-CMs. NPY also correlated with QTc-prolongation in patients being treated for MI and may contribute to the increased incidence of ventricular arrhythmia observed in these patients. Antagonists of Y1 and Y5 receptors may therefore offer an adjunct to β-blockade therapy to reduce the risk of ventricular arrhythmia.

GW24-e1851 an Increase of CO2levels, Enhancing Late Sodium Current, is an Independent Factor of Proarrhythmia in the Heart

GW29-e0421 an Increase in CO2 Levels by Upregulating the Late Sodium Current is Proarrhythmic in the Heart

Modeling the Mechanism of [na+]i Elevation in Heart Failure by a Canine Ventricular Cell Model

Role of CaMKII and PKA in Early Afterdepolarization of Human Ventricular Myocardium Cell: A Computational Model Study

Loss of Luminal Ca 2+ Activation in the Cardiac Ryanodine Receptor is Associated with Ventricular Fibrillation and Sudden Death

Transmural Gradient of Ito and INak Profoundly Influence Ventricular Action Potential Duration

RyR 2 Mutations Linked to Ventricular Tachycardia and Sudden Death Reduce the Threshold for Store-Overload-induced Ca 2 Release ( SOICR )

Tonic Nmda Receptor-Mediated Inward Current In Pre-Sympathetic Pvn Neurons Is Enhanced By Heart Failure.

Abstract 14727: Late Sodium Current Plays a Role in Ventricular Arrhythmias Associated with Increased Intracellular Calcium Concentration

Inhibition of Late Sodium Current Suppresses Calcium-Related Ventricular Arrhythmias by Reducing the Phosphorylation of CaMK-II and Sodium Channel Expressions

Effects of inhibition of endogenous late sodium current on the reverse rate dependence and transmural dispersion of action potential duration prolongation by drugs that inhibit potassium currents

Effect of Ivabradine Prolonging the Cardiac Action Potential Duration With its Proarrhythmic Action in Experimental Rabbitin vitro

ASSA14-03-46 Inhibition of Late Sodium Current Reduces the Reverse Rate Dependence of Action Potential Duration Prolongation Induced by L-type Calcium Channel Activator

Proarrhythmic and Antiarrhythmic Effects of Multiple Ion Channel Inhibitors Modulated by the Late Sodium Current

Late Sodium Current in Synergism with Ca2+/calmodulin-dependent Protein Kinase II Contributes to Β-Adrenergic Activation-Induced Atrial Fibrillation.

High carbachol increases the electrically induced [Ca2+]i transient in the single isolated ventricular myocyte of rats

Small-conductance Ca2+-activated K+ Channels Promote J-wave Syndrome and Phase 2 Reentry

Late Sodium Current in Atrial Cardiomyocytes Contributes to the Induced and Spontaneous Atrial Fibrillation in Rabbit Hearts

Carbon Monoxide Inhibits Inward Rectifier Potassium Channels in Cardiomyocytes

Calmodulin Kinase Ii and Protein Kinase C Mediate the Effect of Increased Intracellular Calcium to Augment Late Sodium Current in Rabbit Ventricular Myocytes

The cardiac sympathetic co-transmitter neuropeptide-Y is pro-arrhythmic in human cardiomyocytes by lengthening activation-recovery interval